About the NEI ORM
The NEI Office of Regenerative Medicine (ORM) provides scientific and administrative support to the vision research community. The ORM facilitates collaboration among scientists across the NIH and other federal agencies, academia, and nonprofit and private research sectors. ORM’s goal is to accelerate progress in regenerative medicine for vision.
Events and Announcements
New Funding Opportunity: NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
Tvst Regenerative Medicine Special Edition released - The NEI Audacious Goals Initiative: Advancing the Frontier of Regenerative Medicine
February 1, 2022 from 3:00 -4:30p EST: NEI ORM Career Pathways Forum – Federal Edition [Trainee Event]
This webinar will focus discussion on different career opportunities in the Federal Government by a group of panelists from the FDA, NSF, and USPTO. A representative from the NIH Office of Human Resources will kick off this event by giving an overview of the Federal hiring process in general, with a focus on USAJobs.
June 1, 2022: 3-D ROC Final Submission Deadline
This is the final phase of 3-D ROC. Solvers must submit by this deadline - see more details here
NEI Vision Innovation Seminars (VIS)
NEI has launched a webinar series to help promote and disseminate cutting-edge research that is relevant to the vision community. Authors of recently published articles will present their work to the research community through this monthly webinar series.
NEI Audacious Goals Initiative (AGI)
NEI is pushing the boundaries of vision science. By facilitating cross-disciplinary research, the AGI is advancing regenerative medicine to tackle the most devastating and difficult-to-treat eye diseases.
NEI 3-D Retina Organoid Challenge (3-D ROC)
3-D ROC is spurring development of robust systems for modeling retinal diseases and testing new regenerative therapies.
NEI AMD Integrative Biology Initiative
NEI is taking the first important steps to correlate phenotypes, genotypes, and imaging information in the newly created AMD Integrative Biology Initiative.
NIH Regenerative Medicine Innovation Project (RMIP)
This trans-NIH effort was established by the 21st Century Cures Act to accelerate progress in the field by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety.
ORM Contacts
|
|
|
|
Tom Greenwell, Ph.D. |
Amber Reed |
